Albert A. Antolín

2.0k total citations
29 papers, 990 citations indexed

About

Albert A. Antolín is a scholar working on Molecular Biology, Computational Theory and Mathematics and Oncology. According to data from OpenAlex, Albert A. Antolín has authored 29 papers receiving a total of 990 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Computational Theory and Mathematics and 9 papers in Oncology. Recurrent topics in Albert A. Antolín's work include Computational Drug Discovery Methods (16 papers), PARP inhibition in cancer therapy (8 papers) and Protein Degradation and Inhibitors (6 papers). Albert A. Antolín is often cited by papers focused on Computational Drug Discovery Methods (16 papers), PARP inhibition in cancer therapy (8 papers) and Protein Degradation and Inhibitors (6 papers). Albert A. Antolín collaborates with scholars based in United Kingdom, Spain and United States. Albert A. Antolín's co-authors include Jordi Mestres, Bissan Al‐Lazikani, Paul Workman, Joseph E Tym, Costas Mitsopoulos, Elizabeth A. Coker, Jordi Deu-Pons, Carlota Rubio-Pérez, Abel González-Pérez and David Tamborero and has published in prestigious journals such as Nucleic Acids Research, The Science of The Total Environment and Cancer Cell.

In The Last Decade

Albert A. Antolín

29 papers receiving 972 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Albert A. Antolín United Kingdom 16 671 306 268 208 97 29 990
Xiaojie Xu China 17 679 1.0× 165 0.5× 249 0.9× 178 0.9× 92 0.9× 54 1.1k
Roberta Bosotti Italy 13 1.0k 1.5× 263 0.9× 420 1.6× 157 0.8× 53 0.5× 28 1.4k
Marc O’Reilly United Kingdom 15 1.0k 1.5× 219 0.7× 158 0.6× 368 1.8× 137 1.4× 20 1.3k
Sukjoon Yoon South Korea 21 702 1.0× 155 0.5× 123 0.5× 219 1.1× 56 0.6× 54 974
Mengzhu Xue China 17 554 0.8× 258 0.8× 120 0.4× 274 1.3× 69 0.7× 31 937
Brent M. Kuenzi United States 13 524 0.8× 331 1.1× 190 0.7× 109 0.5× 34 0.4× 22 923
Ahmed A. Samatar United States 14 1.3k 1.9× 629 2.1× 162 0.6× 249 1.2× 116 1.2× 31 1.7k
Taekyu Lee United States 15 1.2k 1.7× 401 1.3× 168 0.6× 257 1.2× 263 2.7× 35 1.6k
Brinton Seashore‐Ludlow Sweden 20 649 1.0× 186 0.6× 133 0.5× 104 0.5× 298 3.1× 51 1.1k
Manuela Gridling Austria 13 672 1.0× 269 0.9× 74 0.3× 97 0.5× 126 1.3× 17 1.0k

Countries citing papers authored by Albert A. Antolín

Since Specialization
Citations

This map shows the geographic impact of Albert A. Antolín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert A. Antolín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert A. Antolín more than expected).

Fields of papers citing papers by Albert A. Antolín

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert A. Antolín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert A. Antolín. The network helps show where Albert A. Antolín may publish in the future.

Co-authorship network of co-authors of Albert A. Antolín

This figure shows the co-authorship network connecting the top 25 collaborators of Albert A. Antolín. A scholar is included among the top collaborators of Albert A. Antolín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert A. Antolín. Albert A. Antolín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marshall, Vikki M., Frank Lin, David M. Thomas, et al.. (2024). Computational repurposing of oncology drugs through off‐target drug binding interactions from pharmacological databases. Clinical and Translational Medicine. 14(4). e1657–e1657. 1 indexed citations
2.
Hu, Huabin, Carmen Serra, Wenjie Zhang, et al.. (2024). Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite. Cell chemical biology. 31(5). 973–988.e4. 1 indexed citations
3.
Yu, Hui, et al.. (2024). Combining Data-Driven and Structure-Based Approaches in Designing Dual PARP1-BRD4 Inhibitors for Breast Cancer Treatment. Journal of Chemical Information and Modeling. 64(19). 7725–7742. 2 indexed citations
4.
Hu, Huabin, et al.. (2023). A machine learning and live-cell imaging tool kit uncovers small molecules induced phospholipidosis. Cell chemical biology. 30(12). 1634–1651.e6. 5 indexed citations
5.
Bellot, Marina, Eva Prats, Juliette Bedrossiantz, et al.. (2023). Short-term exposure to environmental levels of nicotine and cotinine impairs visual motor response in zebrafish larvae through a similar mode of action: Exploring the potential role of zebrafish α7 nAChR. The Science of The Total Environment. 912. 169301–169301. 8 indexed citations
6.
Dolciami, Daniela, et al.. (2022). canSAR chemistry registration and standardization pipeline. Journal of Cheminformatics. 14(1). 28–28. 12 indexed citations
7.
Micco, Patrizio Di, Albert A. Antolín, Costas Mitsopoulos, et al.. (2022). canSAR: update to the cancer translational research and drug discovery knowledgebase. Nucleic Acids Research. 51(D1). D1212–D1219. 19 indexed citations
8.
Antolín, Albert A., Paul A. Clarke, Ian Collins, Paul Workman, & Bissan Al‐Lazikani. (2021). Evolution of kinase polypharmacology across HSP90 drug discovery. Cell chemical biology. 28(10). 1433–1445.e3. 17 indexed citations
9.
Antolín, Albert A., et al.. (2021). Identification of different side effects between PARP inhibitors and their polypharmacological multi‐target rationale. British Journal of Clinical Pharmacology. 88(2). 742–752. 47 indexed citations
10.
Antolín, Albert A., Malaka Ameratunga, Udai Banerji, et al.. (2020). The kinase polypharmacology landscape of clinical PARP inhibitors. Scientific Reports. 10(1). 2585–2585. 80 indexed citations
11.
Mitsopoulos, Costas, Patrizio Di Micco, Daniela Dolciami, et al.. (2020). canSAR: update to the cancer translational research and drug discovery knowledgebase. Nucleic Acids Research. 49(D1). D1074–D1082. 64 indexed citations
12.
Antolín, Albert A., et al.. (2017). Objective, Quantitative, Data-Driven Assessment of Chemical Probes. Cell chemical biology. 25(2). 194–205.e5. 51 indexed citations
13.
Antolín, Albert A., Paul Workman, Jordi Mestres, & Bissan Al‐Lazikani. (2016). Polypharmacology in Precision Oncology: Current Applications and Future Prospects. Current Pharmaceutical Design. 22(46). 6935–6945. 69 indexed citations
14.
Rubio-Pérez, Carlota, David Tamborero, M. Schroeder, et al.. (2015). In Silico Prescription of Anticancer Drugs to Cohorts of 28 Tumor Types Reveals Targeting Opportunities. Cancer Cell. 27(3). 382–396. 217 indexed citations
15.
Tym, Joseph E, Costas Mitsopoulos, Elizabeth A. Coker, et al.. (2015). canSAR: an updated cancer research and drug discovery knowledgebase. Nucleic Acids Research. 44(D1). D938–D943. 98 indexed citations
16.
Rubio-Pérez, Carlota, David Tamborero, M. Schroeder, et al.. (2015). Abstract 2983: In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals novel targeting opportunities. Cancer Research. 75(15_Supplement). 2983–2983. 2 indexed citations
17.
Rubio-Pérez, Carlota, David Tamborero, M. Schroeder, et al.. (2015). Abstract A1-45: In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals novel targeting opportunities. Cancer Research. 75(22_Supplement_1). A1–45. 2 indexed citations
18.
Antolín, Albert A. & Jordi Mestres. (2014). Linking off-target kinase pharmacology to the differential cellular effects observed among PARP inhibitors. Oncotarget. 5(10). 3023–3028. 44 indexed citations
19.
Antolín, Albert A., Andrea Carotti, Roberto Nuti, et al.. (2013). Exploring the effect of PARP-1 flexibility in docking studies. Journal of Molecular Graphics and Modelling. 45. 192–201. 15 indexed citations
20.
Antolín, Albert A., et al.. (2012). Identification of Pim Kinases as Novel Targets for PJ34 with Confounding Effects in PARP Biology. ACS Chemical Biology. 7(12). 1962–1967. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaojie Xu Breakdown of academic impact, for papers by Roberta Bosotti Breakdown of academic impact, for papers by Marc O’Reilly Breakdown of academic impact, for papers by Sukjoon Yoon Breakdown of academic impact, for papers by Mengzhu Xue Breakdown of academic impact, for papers by Brent M. Kuenzi Breakdown of academic impact, for papers by Ahmed A. Samatar Breakdown of academic impact, for papers by Taekyu Lee Breakdown of academic impact, for papers by Brinton Seashore‐Ludlow Breakdown of academic impact, for papers by Manuela Gridling
Rankless by CCL
2026